The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders

Human Reproduction Update

Volumn 20, Issue 6, 2014, Pages 869-883

  Persani, Luca ^a,b   Rossetti, Raffaella ^a   Di pasquale, Elisa ^c   Cacciatore, Chiara ^a,b   Fabre, Stéphane ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c Milan Unit   (Italy)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bone morphogenetic protein 15; Female infertility; Growth and differentiation factor 9; Polycystic ovary syndrome; Primary ovarian insufficiency

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; FOLLITROPIN; GROWTH DIFFERENTIATION FACTOR 9; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; DIMERIZATION; DIZYGOTIC TWINS; DNA SYNTHESIS; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILITY; FERTILIZATION IN VITRO; GALLUS GALLUS; GENE LOCUS; GENETIC ASSOCIATION; HAPLOINSUFFICIENCY; HUMAN; MISSENSE MUTATION; MOUSE; NONHUMAN; OOCYTE DEVELOPMENT; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION; PHENOTYPE; PREMATURE OVARIAN FAILURE; PROGESTERONE RELEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHEEP; SYSTEMATIC REVIEW; TURNER SYNDROME; X CHROMOSOME; XENOPUS LAEVIS; ZEBRA FISH; ANIMAL; ANIMAL MODEL; FEMALE; GRANULOSA CELL; METABOLISM; OOCYTE; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 15; FEMALE; FERTILITY; GRANULOSA CELLS; GROWTH DIFFERENTIATION FACTOR 9; HUMANS; INFERTILITY, FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, ANIMAL; OOCYTES; OVARIAN FOLLICLE; OVARY; OVULATION; POLYCYSTIC OVARY SYNDROME; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84913528394     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmu036     Document Type: Article

References (150)

1. Al-Musawi SL,Walton KL, Heath D, Simpson CM, Harrison CA. Species differences in the expression and activity of bone morphogenetic protein 15. Endocrinology 2013; 154:888-899.
2. Assidi M, Dufort I, Ali A, Hamel M, Algriany O, Dielemann S, Sirard MA. Identification of potential markers of oocyte competence expressed in bovine cumulus cells matured with follicle-stimulating hormone and/or phorbol myristate acetate in vitro. Biol Reprod 2008;79:209-222.
3. Auclair S, Rossetti R, Meslin C, Monestier O, Di Pasquale E, Pascal G, Persani L, Fabre S. Positive selection in bone morphogenetic protein 15 targets a natural mutation associated with primary ovarian insufficiency in human. PLoS One 2013;8:e78199.
4. Bates TJ, Vonica A, Heasman J, Brivanlou AH, Bell E. Coco regulates dorsoventral specification of germ layers via inhibition of TGFb signalling. Development 2013; 140:4177-4181.
5. Buccione R, Vanderhyden BC, Caron PJ, Eppig JJ. FSH-induced expansion of the mouse cumulus oophorus in vitro is dependent upon a specific factor(s) secreted by the oocyte. Dev Biol 1990;138:16-25.
6. Caixeta ES, Sutton-Mcdowall ML, Gilchrist RB, Thompson JG, Price CA, Machado MF, Lima PF, Buratini J. Bone morphogenetic protein 15 and fibroblast growth factor 10 enhance cumulus expansion, glucose uptake, and expression of genes in the ovulatory cascade during in vitro maturation of bovine cumulus-oocyte complexes. Reproduction 2013;146:27-35.
7. Canipari R, Epifano O, Siracusa G, Salustri A. Mouse oocytes inhibit plasminogen activator production by ovarian cumulus and granulosa cells. Dev Biol 1995; 167:371-378.
8. Castronovo C,Rossetti R,Rusconi D,Recalcati MP,Cacciatore C,Beccaria E,Calcaterra V, Invernizzi P, Larizza D,Finelli P et al. Genedosage as a relevantmechanismcontributing to the determination of ovarian function in Turner syndrome. Hum Reprod 2013;8:8.
9. Chand AL, PonnampalamAP, Harris SE, Winship IM, Shelling AN. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril 2006; 86:1009-1012.
10. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002;23:787-823.
11. Chang HM, Cheng JC, Klausen C, Leung PC. BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells. Mol Endocrinol 2013;27:2093-2104.
12. Clelland E, Kohli G, Campbell RK, Sharma S, Shimasaki S, Peng C. Bone morphogenetic protein-15 in the zebrafish ovary: complementary deoxyribonucleic acid cloning, genomic organization, tissue distribution, and role in oocyte maturation. Endocrinology 2006;147:201-209.
13. Clelland ES, Tan Q, Balofsky A, Lacivita R, Peng C. Inhibition of premature oocyte maturation: a role for bone morphogenetic protein 15 in zebrafish ovarian follicles. Endocrinology 2007;148:5451-5458.
14. Clelland ES, Kelly SP. ExogenousGDF9but not activin A, BMP15 or TGFbeta alters tight junction protein transcript abundance in zebrafish ovarian follicles. Gen Comp Endocrinol 2011;171:211-217.
15. Demars J, Fabre S, Sarry J, Rossetti R, Gilbert H, Persani L, Tosser-Klopp G, Mulsant P, Nowak Z, Drobik W et al. Genome-wide association studies identify two novel BMP15 mutations responsible for an atypical hyperprolificacy phenotype in sheep. PLoS Genet 2013;9:e1003482.
16. De Resende LO, Vireque AA, Santana LF, Moreno DA, De Sa Rosa E, Silva AC, Ferriani RA, Scrideli CA, Reis RM. Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation. J Assist Reprod Genet 2012;29:1057-1065.
17. Di Pasquale E, Brivanlou AH. Bone morphogenetic protein 15 (BMP15) acts as a BMP andWnt inhibitor during early embryogenesis. J Biol Chem 2009;284:26127-26136.
18. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004;75:106-111.
19. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, Einaudi S, Radetti G, Russo G, Sacco M et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 2006;91:1976-1979.
20. Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, Chakravarty B, Singh L. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 2005;12:749-754.
21. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty B, Singh L. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 2006;119:408-415.
22. DongJ, AlbertiniDF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996;383:531-535.
23. Dube JL,Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 1998; 12:1809-1817.
24. Edry I, Sela-Abramovich S, Dekel N. Meiotic arrest of oocytes depends on cell-to-cell communication in the ovarian follicle. Mol Cell Endocrinol 2006;252:102-106.
25. Elis S, Dupont J, Couty I, Persani L, Govoroun M, Blesbois E, Batellier F, Monget P. Expression and biological effects of bone morphogenetic protein-15 in the hen ovary. J Endocrinol 2007;194:485-497.
26. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999;13:1035-1048.
27. Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001;122:829-838.
28. Eppig JJ, Pendola FL, Wigglesworth K. Mouse oocytes suppress cAMP-induced expression of LH receptor mRNA by granulosa cells in vitro. Mol Reprod Dev 1998;49:327-332.
29. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci USA 2002;99:2890-2894.
30. Fabre S, Pierre A, Mulsant P, Bodin L, Di Pasquale E, Persani L, Monget P, Monniaux D. Regulation of ovulation rate in mammals: contribution of sheep genetic models. Reprod Biol Endocrinol 2006;4:20.
31. Fenwick MA, Mora JM, Mansour YT, Baithun C, Franks S, Hardy K. Investigations of TGF-beta signaling in preantral follicles of female mice reveal differential roles for bone morphogenetic protein 15. Endocrinology 2013;154:3423-3436.
32. Ferrarini E, Russo L, Fruzzetti F, Agretti P, De Marco G, Dimida A, Gianetti E, Simoncini T, Simi P, Baldinotti F et al. Clinical characteristics and genetic analysis in women with premature ovarian insufficiency. Maturitas 2013;74:61-67.
33. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000;25:279-283.
34. Gilchrist RB, Ritter LJ, Armstrong DT. Mouse oocyte mitogenic activity is developmentally coordinated throughout folliculogenesis and meiotic maturation. Dev Biol 2001;240:289-298.
35. Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 2008;14:159-177.
36. Gittens JE, Kidder GM. Differential contributions of connexin37 and connexin43 to oogenesis revealed in chimeric reaggregated mouse ovaries. J Cell Sci 2005; 118:5071-5078.
37. Glister C, GroomeNP, Knight PG. Oocyte-mediated suppression of follicle-stimulating hormone- and insulin-like growth factor-induced secretion of steroids and inhibin-related proteins by bovine granulosa cells in vitro: possible role of transforming growth factor alpha. Biol Reprod 2003;68:758-765.
38. Gode F, Gulekli B, Dogan E, Korhan P, Dogan S, BigeO, Cimrin D, Atabey N. Influence of follicular fluid GDF9 and BMP15 on embryo quality. Fertil Steril 2011; 95:2274-2278.
39. Gonzalez A, Ramirez-Lorca R, Calatayud C, Mendoza N, Ruiz A, Saez ME, Moron FJ. Association of genetic markers within the BMP15 gene with anovulation and infertility in women with polycystic ovary syndrome. Fertil Steril 2008;90:447-449.
40. Gracia Bouthelier R, Oliver Iguacel A, Gonzalez Casado I, Alcalde De Alvare A. Optimization of treatment in Turner's syndrome. J Pediatr Endocrinol Metab 2004; 17:427-434.
41. Guéripel X, Brun V, Gougeon A. Oocyte bone morphogenetic protein 15, but not growth differentiation factor 9, is increased during gonadotropin-induced follicular development in the immature mouse and is associated with cumulus oophorus expansion. Biol Reprod 2006;75:836-843.
42. Gui LM, Joyce IM. RNA interference evidence that growth differentiation factor-9 mediates oocyte regulation of cumulus expansion in mice. Biol Reprod 2005; 72:195-199.
43. Hagemann LJ. Influence of the dominant follicle on oocytes from subordinate follicles. Theriogenology 1999;51:449-459.
44. Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA. A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod Biomed Online 2011;23:97-104.
45. Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, Galloway SM. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 2004;70:900-909.
46. Hashimoto O, Moore RK, Shimasaki S. Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. Proc Natl Acad Sci USA 2005;102:5426-5431.
47. Heasman J. Maternal determinants of embryonic cell fate. Semin Cell Dev Biol 2006; 17:93-98.
48. Hill CS. TGF-beta signalling pathways in early Xenopus development. Curr Opin Genet Dev 2001;11:533-540.
49. Hussein TS, Froiland DA, Amato F, Thompson JG, Gilchrist RB. Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci 2005;118:5257-5268.
50. Hussein TS, Thompson JG, Gilchrist RB. Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol 2006;296:514-521.
51. Inagaki K, Shimasaki S. Impaired production of BMP-15 and GDF-9 mature proteins derived from proproteins with mutations in the proregion. Mol Cell Endocrinol 2010;328:1-7.
52. Johnson PA, Dickens MJ, Kent TR, Giles JR. Expression and function of growth differentiation factor-9 in an oviparous species, Gallus domesticus. Biol Reprod 2005;72:1095-1100.
53. Joyce IM, Pendola FL, Wigglesworth K, Eppig JJ. Oocyte regulation of kit ligand expression in mouse ovarian follicles. Dev Biol 1999;214:342-353.
54. Juengel JL, Hudson NL, Heath DA, Smith P, Reader KL, Lawrence SB, O'Connell AR, Laitinen MP, Cranfield M, Groome NP et al. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod 2002;67:1777-1789.
55. Juengel JL, Hudson NL, Whiting L, McNatty KP. Effects of immunization against bone morphogenetic protein 15 and growth differentiation factor 9 on ovulation rate, fertilization, and pregnancy in ewes. Biol Reprod 2004;70:557-561.
56. Juengel JL,HudsonNL, Berg M, Hamel K, Smith P, Lawrence SB,Whiting L, McNatty KP. Effects of active immunization against growth differentiation factor 9 and/or bone morphogeneticprotein15onovarian function incattle. Reproduction 2009;138:107-114.
57. Kaivo-Oja N, Bondestam J, Kämäräinen M, Koskimies J, Vitt U, Cranfield M, Vuojolainen K, Kallio JP, Olkkonen VM, Hayashi M et al. Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 2003;88:755-762.
58. Kaivo-Oja N, Mottershead DG, Mazerbourg S, Myllymaa S, Duprat S, Gilchrist RB, Groome NP, Hsueh AJ, Ritvos O. Adenoviral gene transfer allows Smadresponsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells. J Clin Endocrinol Metab 2005;90:271-278.
59. Kimelman D, Pyati UJ. Bmp signaling: turning a half into a whole. Cell 2005; 123:982-984.
60. Kovanci E, Rohozinski J, Simpson JL, Heard MJ, Bishop CE, Carson SA. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril 2007;87:143-146.
61. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 2006;154:739-744.
62. Laitinen M, Vuojolainen K, Jaatinen R, Ketola I, Aaltonen J, Lehtonen E, Heikinheimo M, Ritvos O. A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev 1998;78:135-140.
63. Lan ZJ, Gu P, Xu X, Jackson KJ, Demayo FJ, O'Malley BW, Cooney AJ. GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility. EMBO J 2003;22:4070-4081.
64. Layman LC. Editorial: BMP15-the first true ovarian determinant gene on the X-chromosome? J Clin Endocrinol Metab 2006;91:1673-1676.
65. Ledig S, Röpke A, Haeusler G, Hinney B, Wieacker P. BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. Am J Obstet Gynecol 2008; 198:84.e1-5.
66. Li Q, Rajanahally S, Edson MA, Matzuk MM. Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15. Mol Hum Reprod 2009;15:779-788.
67. Li Q, Agno JE, Edson MA, Nagaraja AK, Nagashima T, Matzuk MM. Transforming growth factor b receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genet 2011;7:e1002320.
68. Liao J,Wolfman JC,Wolfman A. K-ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts. J Biol Chem 2003;278:31871-31878.
69. Liao WX, Moore RK, Shimasaki S. Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem 2004; 279:17391-17396.
70. Lin JY, Pitman-Crawford JL, Bibby AH, Hudson NL, Mcintosh CJ, Juengel JL, McnattyKP. Effects of species differences on oocyte regulation of granulosa cell function. Reproduction 2012;144:557-567.
71. Lin ZL, Li YH, Xu YN, Wang QL, Namgoong S, Cui XS, Kim NH. Effects of growth differentiation factor 9 and bone morphogenetic protein 15 on the in vitro maturation of porcine oocytes. Reprod Domest Anim 2013;9:12254.
72. Liu L, Ge W. Growth differentiation factor 9 and its spatiotemporal expression and regulation in the zebrafish ovary. Biol Reprod 2007;76:294-302.
73. Liu J,Wang B,Wei Z, Zhou P, Zu Y, Zhou S,WenQ,Wang J, Cao Y, Ma X. Mutational analysis of human bone morphogenetic protein 15 in Chinesewomenwith polycystic ovary syndrome. Metabolism 2011;60:1511-1514.
74. Lonergan P, Monaghan P, Rizos D, Boland MP, Gordon I. Effect of follicle size on bovine oocyte quality and developmental competence following maturation, fertilization, and culture in vitro. Mol Reprod Dev 1994;37:48-53.
75. Martin Campagne E, Roa Llamazares C. Spontaneous puberty and menarche in a patient with Turner syndrome and 45X monosomy. An Pediatr (Barc) 2009; 70:200-202.
76. Mazerbourg S, Klein C, RohJ, Kaivo-Oja N, MottersheadDG, Korchynskyi O, RitvosO, Hsueh AJ. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol 2004;18:653-665.
77. McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell 1993;73:421-424.
78. McGrath SA, Esquela AF, Lee S. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995;9:131-136.
79. McGuire MM, BowdenW, Engel NJ, AhnHW, Kovanci E, Rajkovic A. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. Fertil Steril 2011; 95:1595-1600.
80. Mcintosh CJ, Lun S, Lawrence S,WesternAH, McNattyKP, Juengel JL. The proregion of mouse BMP15 regulates the cooperative interactions of BMP15 and GDF9. Biol Reprod 2008;79:889-896.
81. McIntosh CJ, Lawrence S, Smith P, Juengel JL, McNatty KP. Active immunization against the proregions of GDF9 or BMP15 alters ovulation rate and litter size in mice. Reproduction 2012;143:195-201.
82. McLeodBJ, FentonLF,DavisGH,BruceGD,ManleyTR, JohnstonePD. Identifying infertile homozygous Inverdale (FecXI) ewe lambs on the basis of genotype differences in reproductive hormone concentrations. Anim Reprod Sci 1997;47:291-302.
83. McMahon HE, Hashimoto O, Mellon PL, Shimasaki S. Oocyte-specific overexpression of mouse bone morphogenetic protein-15 leads to accelerated folliculogenesis and an early onset of acyclicity in transgenic mice. Endocrinology 2008;149:2807-2815.
84. McNatty KP, Moore LG, Hudson NL, Quirke LD, Lawrence SB, Reader K, Hanrahan JP, Smith P, Groome NP, LaitinenMet al. The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction 2004;128:379-386.
85. McNatty KP, Galloway SM, Wilson T, Smith P, Hudson NL, O'Connell A, Bibby AH, Heath DA, Davis GH, Hanrahan JP et al. Physiological effects of major genes affecting ovulation rate in sheep. Genet Sel Evol 2005a;37:S25-S38.
86. McNatty KP, Juengel JL, Reader KL, Lun S, Myllymaa S, Lawrence SB, Western A, Meerasahib MF, Mottershead DG, Groome NP et al. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function. Reproduction 2005b;129:473-480.
87. McNatty KP, Juengel JL, Reader KL, Lun S, Myllymaa S, Lawrence SB, Western A, Meerasahib MF, Mottershead DG, Groome NP et al. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction 2005c;129:481-487.
88. McNatty KP, Hudson NL, Whiting L, Reader KL, Lun S,Western A, Heath DA, Smith P, Moore LG, Juengel JL. The effects of immunizing sheep with different BMP15 orGDF9 peptide sequences on ovarian follicular activity and ovulation rate. Biol Reprod 2007;76:552-560.
89. McPherron AC, Lee SJ. GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. J Biol Chem 1993;268:3444-3449.
90. Montgomery GW, Zhao ZZ, Marsh AJ, Mayne R, Treloar SA, James M, Martin NG, Boomsma DI, Duffy DL. A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Res 2004;7:548-555.
91. Moore RK, Shimasaki S. Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol 2005;234:67-73.
92. Moore RK, Otsuka F, Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem 2003;278:304-310.
93. Morón FJ, de Castro F, Royo JL, Montoro L, Mira E, Sáez ME, Real LM, González A, Mañes S, Ruiz A. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS). Pharmacogenet Genomics 2006;16:485-495.
94. Mottershead DG, Watson AJ. Oocyte peptides as paracrine tools for ovarian stimulation and oocyte maturation. Mol Hum Reprod 2009;15:789-794.
95. Mottershead DG, Ritter LJ, Gilchrist RB. Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15. Mol Hum Reprod 2012; 18:121-128.
96. Mottershead DG, Harrison CA, Mueller TD, Stanton PG, Gilchrist RB, McNatty KP. Growth differentiation factor 9: bone morphogenetic protein 15 (GDF9:BMP15) synergism and protein heterodimerization. Proc Natl Acad Sci USA 2013;110:E2257.
97. Munoz-Sanjuan I, Brivanlou AH. Neural induction, the default model and embryonic stem cells. Nat Rev Neurosci 2002;3:271-280.
98. Nicol L, Bishop SC, Pong-Wong R, Bendixen C, Holm LE, Rhind SM, McNeilly AS. Homozygosity for a single base-pair mutation in the oocyte-specific GDF9 gene results in sterility in Thoka sheep. Reproduction 2009;138:921-933.
99. Onagbesan OM, Bruggeman V, Van As P, Tona K, Williams J, Decuypere E. BMPs and BMPRs in chicken ovary and effects of BMP-4 and -7 on granulosa cell proliferation and progesterone production in vitro. Am J Physiol Endocrinol Metab 2003; 285:E973-E983.
100. Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA 2002;99:8060-8065.
101. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 2000; 275:39523-39528.
102. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 2001;276:11387-11392.
103. Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev 2011;78:9-21.
104. Palmer JS, Zhao ZZ, HoekstraC, Hayward NK,Webb PM, Whiteman DC, Martin NG, Boomsma DI, Duffy DL, MontgomeryGW. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab 2006;91:4713-4716.
105. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J Clin Endocrinol Metab 1997;82:1810-1813.
106. Peng J, Li Q, Wigglesworth K, Rangarajan A, Kattamuri C, Peterson RT, Eppig JJ, Thompson TB, Matzuk MM. Growth differentiation factor 9: bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci USA 2013;110:E776-E785.
107. Persani L, Rossetti R, Cacciatore C, Bonomi M. Primary ovarian insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009;33:35-41.
108. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol 2010;45:257-279.
109. Persani L, Rossetti R, Cacciatore C, Fabre S. Genetic defects of ovarian TGF-b-like factors and premature ovarian failure. J Endocrinol Invest 2011;34:244-251.
110. Pulkki MM, Myllymaa S, Pasternack A, Lun S, Ludlow H, Al-Qahtani A, Korchynskyi O, Groome N, Juengel JL, Kalkkinen N et al. The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region. Mol Cell Endocrinol 2011; 332:106-115.
111. Pulkki MM, Mottershead DG, Pasternack AH, Muggalla P, Ludlow H, van Dinther M, Myllymaa S, Koli K, ten Dijke P, Laitinen M et al. A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells. Endocrinology 2012;153:1509-1518.
112. Reader KL, Heath DA, Lun S, Mcintosh CJ, Western AH, Littlejohn RP, Mcnatty KP, Juengel JL. Signalling pathways involved in the cooperative effects of ovine and murine GDF9+BMP15-stimulated thymidine uptake by rat granulosa cells. Reproduction 2011;142:123-131.
113. Rossetti R, Di Pasquale E, Marozzi A, Bione S, Toniolo D, Grammatico P, Nelson LM, Beck-Peccoz P, Persani L. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat 2009; 30:804-810.
114. Saito S, Yano K, Sharma S, Mcmahon HE, Shimasaki S. Characterization of the post-translational modification of recombinant human BMP-15 mature protein. Protein Sci 2008;17:362-370.
115. Sengle G, Ono RN, Sasaki T, Sakai LY. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J Biol Chem 2011;286: 5087-5099.
116. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocrine Rev 2004;25:72-101.
117. Silva BD, Castro EA, Souza CJ, Paiva SR, Sartori R, Franco MM, Azevedo HC, Silva TA, Vieira AM, Neves JP et al. A new polymorphism in the growth and differentiation factor 9 (GDF9) gene is associated with increased ovulation rate and prolificacy in homozygous sheep. Anim Genet 2011;42:89-92.
118. Simpson CM, Robertson DM, Al-Musawi SL, Heath DA, McNatty KP, Ritter LJ, Mottershead DG, Gilchrist RB, Harrison CA, Stanton PG. Aberrant GDF9 expression and activation is associated with common human ovarian disorders. J Clin Endocrinol Metab 2014;99:E615-624.
119. Smith P, O WS, Corrigan KA, Smith T, Lundy T, Davis GH, McNatty KP. Ovarian morphology and endocrine characteristics of female sheep fetuses that are heterozygous or homozygous for the inverdale prolificacy gene (fecX1). Biol Reprod 1997;57:1183-1192.
120. Sproul K, Jones MR, Mathur R, Azziz R, Goodarzi MO. Association study of four key folliculogenesis genes in polycystic ovary syndrome. BJOG 2010;117:756-760.
121. Stern CD. Neural induction: old problem, new findings, yet more questions. Development 2005;132:2007-2021.
122. Su YQ, Sugiura K, Wigglesworth K, O'brien MJ, Affourtit JP, Pangas SA, Matzuk MM, Eppig JJ. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development 2008;135:111-121.
123. Sugiura K, Eppig JJ., Society for Reproductive Biology Founders' Lecture 2005. Control ofmetabolic cooperativity between oocytes and their companion granulosa cells by mouse oocytes. Reprod Fertil Dev 2005;17:667-674.
124. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227-1238.
125. Takebayashi K, Takakura K,Wang H, Kimura F, Kasahara K, Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 2000;74:976-979.
126. Tanghe S, VanSoomA,Nauwynck H, Coryn M,DeKruif A. Minireview: functions of the cumulus oophorus during oocyte maturation, ovulation, and fertilization. Mol Reprod Dev 2002;61:414-424.
127. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S, Erickson GF. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87:1337-1344.
128. Tiotiu D, Alvaro Mercadal B, Imbert R, Verbist J, Demeestere I,De Leener A, Englert Y, Vassart G, Costagliola S, Delbaere A. Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod 2010;25:1581-1587.
129. Toniolo D. X-linked premature ovarian failure: a complex disease. Curr Opin Genet Dev 2006;16:293-300.
130. Våge DI, Husdal M, Kent MP, Klemetsdal G, Boman IA. A missense mutation in growth differentiation factor 9 (GDF9) is strongly associated with litter size in sheep. BMC Genet 2013;14:1.
131. Vanderhyden BC,Telfer EE, Eppig JJ. Mouse oocytes promote proliferation of granulosa cells from preantral and antral follicles in vitro. Biol Reprod 1992;46:1196-1204.
132. Vanderhyden BC, Cohen JN, Morley P. Mouse oocytes regulate granulosa cell steroidogenesis. Endocrinology 1993;133:423-426.
133. Veitch GI, Gittens JE, Shao Q, LairdDW, Kidder GM. Selective assembly of connexin37 into heterocellular gap junctions at the oocyte/granulosa cell interface. J Cell Sci 2004;117:2699-2707.
134. Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 2000a;62:370-377.
135. Vitt UA, McGee EA, Hayashi M, Hsueh AJ. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 2000b;141:3814-2380.
136. Vitt UA, Mazerbourg S, Klein C, Hsueh AJ. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol Reprod 2002;67:473-480.
137. Vonica A, Brivanlou AH. The left-right axis is regulated by the interplay of Coco, Xnr1 and derriere in Xenopus embryos. Dev Biol 2007;303:281-294.
138. Wang B,WenQ,Ni F, Zhou S,Wang J, Cao Y, Ma X. Analyses of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) mutation in Chinese women with premature ovarian failure. Clin Endocrinol (Oxf) 2010;72:135-136.
139. Wang TT, Ke ZH, Song Y, Chen LT, Chen XJ, Feng C, Zhang D, Zhang RJ, Wu YT, Zhang Y et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod 2013;28:2473-2481.
140. Wei LN, LiangXY, Fang C,Zhang MF.Abnormal expressionof growthdifferentiationfactor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome. Fertil Steril 2011;96:464-468.
141. Wei LN, Li LL, Fang C, Huang R, Liang XY. Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS. J Assist Reprod Genet 2013;30:1313-1318.
142. Wilson PA, Lagna G, Suzuki A, Hemmati-Brivanlou A. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. Development 1997;124:3177-3184.
143. Wu YT,Tang L,Cai J, Lu XE,Xu J,Zhu XM, Luo Q,Huang HF.High bonemorphogenetic protein-15 level in follicular fluid is associatedwith high quality oocyte and subsequent embryonic development. Hum Reprod 2007;22:1526-1531.
144. Wu YT,Wang TT, Chen XJ, Zhu XM, Dong MY, Sheng JZ, Xu CM, Huang HF. Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders. Reprod Biol Endocrinol 2012;10:116.
145. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 2001; 15:854-866.
146. YeoCX, Gilchrist RB,Thompson JG, Lane M. Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice. Hum Reprod 2008;23:67-73.
147. Zhang P, Shi YH,Wang LC, Chen ZJ. Sequence variants in exons of the BMP-15 gene in Chinese patients with premature ovarian failure. Acta Obstet Gynecol Scand 2007; 86:585-589.
148. Zhang LP, Gan QF, Zhang XH, Li HD, Hou GY, Li JY, Gao X, Ren HY, Chen JB, Xu SZ. Detecting a deletion in the coding region of the bovine bone morphogenetic protein 15 gene (BMP15). J Appl Genet 2009;50:145-148.
149. Zhao ZZ, Painter JN, Palmer JS, Webb PM, Hayward NK, Whiteman DC, Boomsma DI, Martin NG, Duffy DL, Montgomery GW. Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning. Hum Reprod 2008;23:2372-2379.
150. Zinn AR, Ross JL. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998; 8:322-327.